The RVC is the oldest veterinary school in the English-speaking world, and the creation of the College in 1791 marked the establishment of the veterinary profession in Britain.
To mark its 225 years and celebrate the heritage of veterinary and scientific education, the RVC invited alumni back to attend a programme of events, including a gala dinner on Saturday and an Open Day and Campus Tour on Sunday.
Sunday’s activities included displays focusing on the history of the RVC, talks, a film screening and an ethical debate. The ethical debate related to the balance between business and welfare in all aspects of veterinary work. There were events for staff at both the Camden and Hertfordshire campuses on the Friday to mark the College’s birthday.
RVC Principal Stuart Reid said: "It is a great honour to lead the RVC, which has achieved so much over the centuries, within this era of so many exciting breakthroughs. The College has always looked beyond the horizon to make advancements in science and practice, for the benefit of patients and communities globally, yet it is crucial to also recognise the essential contributions of those who have gone before. The early pioneers and those who followed them played essential roles in the evolution of both veterinary and human medicine and the advancement of science.
"As we celebrate 225 years as a world-leading institution, we honour all who have worked and studied here through the centuries. Our current advances in knowledge are built on the efforts of all who have been part of the RVC through the centuries. By acknowledging this heritage, we also reflect on how efforts being made today by researchers, practitioners and students have long-term implications for animal health and welfare globally."
Dan Forster MRCVS and his wife Kirsty, a veterinary nurse, run The Mobile Vet Ltd, which offers a 24/7 mobile service to clients and their animals on the Isle of Wight. The team work out of custom-designed vehicles, as well as their fully equipped static veterinary clinic in Newport.
In launching The Mobile Vet, their vision was to create a mobile clinic which could provide all of the services normally provided in a traditional clinic rather than just some. The veterinary team uses the latest technology and veterinary software to communicate with clients and works from vehicles specifically designed by Dan and Kirsty.
The Queen’s Awards for Enterprise are awarded to businesses for outstanding achievement in International Trade, Innovation and Sustainable Development. Winners of the Innovation Awards are judged to have shown outstanding success as the result of an innovation.
Dan said: "We aim to offer a caring and professional service to Islanders and their pets while also maintaining a good work/life balance. We can do almost everything from our vehicles but, when necessary, we utilise our fully equipped static clinic. We aim to offer a highly professional veterinary service using state-of-the-art equipment, which is also convenient to our clients. We have recently introduced a CT scanning service and laparoscopic surgery to expand our clinical services further.
"We are honoured to receive this prestigious award and had a fantastic day. The Award would never have been achievable without the support of our wonderful team. We look forward to continuing to provide an exemplary level of service to our clients."
Sileo provides a micro-dose of dexmedetomidine hydrochloride, a selective alpha-2 adrenoceptor agonist which Zoetis says helps a dog calm down or remain calm yet fully functional in situations involving fear-eliciting sounds.
Sileo is presented as an oromucosal gel formulation in a 3ml oral syringe that can be used to apply multiple doses.
Zoetis says that its user-friendly application means that, once prescribed, it can be given by the dog owner and used only when needed for each noise anxiety event. It takes effect within 15 - 60 minutes and last for 2-3 hours. Should the fear-eliciting noise continue, further doses can be given at two hour intervals up to a total of five times during each noise event.
The company says that even when the full dosing limit is used, the dog will remain functional during treatment; the clinical effects of dexmedetomidine are dose-dependent and the anxiolytic effect is reached before the sedative effect.
Animal behaviourist, Jon Bowen BVetMed DipAS (CABC) MRCVS, said: "Fear of seasonal loud noises such as fireworks, thunder and gunshots are known to affect around 50% of the UK dog population but the prevalence of fears of other everyday noises and the extent to which those fears contribute to nuisance and problem behaviour in dogs is something we are researching at the moment. Sileo is ideal as an acute anxiolytic for planned or expected events such as fireworks or thunder, but it has an even wider range of potential applications in planned events that involve stressful noise exposure including travel, social gatherings and even visits to the vet."
Sileo is available to order now via your veterinary wholesaler.
For more information contact your Zoetis account manager or customer support on 0854 300 8034 or visit www.zoetis.co.uk/Sileo.
BVA President Gudrun Ravetz said: "Veterinary View not only highlights some of the veterinary profession's fantastic work, but complements our joint project with RCVS, Vet Futures, in exploring how the profession can best shape its own future. We hope it will stimulate debate among vets, and the wider community in which we work, about both the big challenges and opportunities that the veterinary profession is facing."
The series includes a number of videos which showcase more recent industry developments:
Stem Cell therapy for the treatment of canine osteoarthritis (VetCell Therapeutics)
Pharmtrax, a mobile device for vets to record work and dispensing on the farm (Henry Schein Animal Health)
Hormone implants as an alternative to castration (Virbac Animal Health)
Practice management support from Zoetis
Preventing an epidemic of equine flu (Merial Animal Health)
Under the Petplan Portfolio Rewards scheme, each time a practice generates a full policy (including clients continuing cover from IVC /4 week free policies) they earn Portfolio Rewards credits.
A practice issuing Immediate Veterinary Cover (IVC) ordinarily earns 150 credits when the client continues their cover onto a full policy but, during this promotion, a full policy generated by an IVC will earn 300 credits, equivalent to £12.
Credits can then be exchanged against a range of products, from essential veterinary equipment and specialised literature to a variety of indulgences including chocolates and bottles of wine, leisure activities or team nights out.
Head of Sales & Partnerships at Petplan, James Barnes said: "Petplan is the UK’s no 1 pet insurance provider and our unique relationship with the veterinary profession remains an important part of our success so we wanted to do something extra to thank practices for their efforts promoting Petplan insurance to their clients during 2016. We know many practices like to exchange their Portfolio Rewards at Christmas so this promotion gives practices the chance to boost their account before the festive season."
For further information about the scheme or working with Petplan, visit petplanvet.co.uk.
The nomination period runs up until 5pm on Tuesday 31 January 2017. In order to stand, candidates need to submit a nomination form, submit a short biography and personal statement and supply a high resolution digital photo.
Each candidate also needs two nominators who are veterinary surgeons on the College’s Register but who are not current RCVS Council members.
Dr Chris Tufnell, RCVS President, said: "As someone who has been a member of Council since 2009 I can honestly say that the discussions you have and the decisions you make through both Council and its various committees do have a tangible impact on the future of the profession.
"For example, in my relatively short time as a Council member I have been involved in the review of specialisation in the profession and the setting up of Advanced Practitioner status, the championing of primary care as a valuable discipline in its own right and overseen the delivery of an ambitious Strategic Plan through my position on the Operational Board.
"These are all areas that I never imagined I’d be able to influence from my position as a practising vet in general practice. So, if you are interested in having a say in issues as varied as CPD policy and how we respond to the challenges and opportunities of Brexit, then please put yourself forward for Council."
Prospective candidates are invited to attend a ‘Meet the RCVS Day’ at the College’s offices in Belgravia House, London, on Wednesday 23 November 2016 where they will have the opportunity to talk to RCVS President Chris Tufnell and find out more about the role of the College, its Councils and its committees.
Those interested in attending should contact Emma Lockley, RCVS Events Officer, on e.lockley@rcvs.org.uk or 020 7202 0773. Reasonable expenses for travel will be reimbursed.
The election period starts around mid-March and will run until 5pm on Friday 28 April 2017. Ballot papers will be sent to veterinary surgeons who are eligible to vote in the week commencing Monday 13 March 2017.
Nomination forms, guidance notes and frequently asked questions for prospective RCVS Council candidates can be found at www.rcvs.org.uk/rcvscouncil17.
The letter outlines how the organisations want to work with the government to ensure the best possible outcome for animal health and welfare, public health and the veterinary profession post-Brexit, but also voices concern that perceptions of ‘anti-foreigner’ rhetoric may already be having an impact on the veterinary workforce.
Here is the full text of the letter sent to the Prime Minister on the afternoon of Tuesday 18 October 2016:
Dear Prime Minister,
Like all professions and sectors, we are currently involved in detailed debates regarding how Brexit is likely to affect our members and how we can best harness the opportunities it may present. We are very keen to work with the government to make a success of Brexit within our sector. The veterinary profession plays a crucial role in protecting public health, relies heavily on EU graduates and is already feeling the impact of the EU referendum.
The UK veterinary profession is made up of over 26,000 veterinary surgeons and over 11,000 veterinary nurses, working to improve the health and welfare of animals, to monitor and control the spread of diseases, and to assure the safety of the food we eat. Each year around 50% of veterinary surgeons registering to practise in the UK are from overseas, with the vast majority coming from the EU. EU veterinary surgeons make a particularly strong contribution to public health critical roles such as working in the Government Veterinary Services. In the meat hygiene sector some estimates suggest 95% of veterinary surgeons graduated overseas. Consequently, Brexit and accompanying changes to the mutual recognition system or immigration restrictions could have a profound impact upon the veterinary workforce.
We are currently considering how best to manage the potential impact on the veterinary workforce, and will be very pleased to discuss these issues with the relevant government departments in due course. However, even before Article 50 is triggered we are experiencing a negative impact on the existing veterinary workforce.
We have received reports that the increasing focus on foreign workers is causing personal distress to individual members of the veterinary profession who live and work in the UK. There are also reports of a negative impact on recruitment and retention: those involved in public health critical roles, such as meat hygiene, are having increasing difficulty recruiting much needed EU veterinary surgeons to work in the UK; leading experts from overseas are turning down employment offers from top UK universities; and many others are considering leaving the UK due to a feeling it is no longer welcoming to foreigners. There is a danger that the language and rhetoric around Brexit, alongside the ongoing uncertainty for non-British EU citizens, could seriously impact the veterinary profession’s ability to fulfil its essential roles.
The government has encouraged professions like ours to present factual data on the EU migration issues so that you can fully understand the challenges the country faces. The RCVS has begun the process of commissioning detailed research into the impact that Brexit is having upon those working in the profession and the implications this could have for the veterinary workforce. We will keep your officials informed as to the results of this research.
In the meantime, we reiterate our call for the government to protect the status of non-British EU vets and vet nurses currently working and studying in the UK, and urge Ministers to be mindful of the negative impact of what may be perceived as ‘anti-foreigner’ rhetoric.
We are committed to working with you to identify opportunities created by Brexit for animal health and welfare, public health and veterinary research and to realise our joint vision for the UK to continue to lead in these areas, and we are keen to maintain close communication with you and your colleagues as the negotiations develop.
Yours sincerely,
Chris Tufnell, President, Royal College of Veterinary SurgeonsGudrun Ravetz, President, British Veterinary Association
Buprelieve is a 0.3mg/ml buprenorphine solution for injection, licensed for post-operative analgesia and to potentiate the sedative effects of other centrally-acting agents in dogs and horses. It can be administered by intramuscular or intravenous injection to dogs and cats and by intravenous injection to horses and is available in 10ml multi-dose glass vials.
Dr Rich Irvine BVSc MRCVS, veterinary services manager at Jurox (UK) Limited said: "We are delighted to be extending our range of products with the launch of Buprelieve which will provide veterinary practices with effective and economical analgesia.
"The launch of Buprelieve will be supported by our highly qualified team of veterinary surgeons who aim to deliver top quality help, advice and assistance for clinics wishing to perform best practice anaesthesia across all patient groups."
Jurox says it has been listening to the concerns of veterinary surgeons who say they want high quality generic medicines at affordable prices along with transparency as to what they are paying for each vial. As a result, the company says it is launching Buprelieve at a very affordable list price with a simple and generous introductory offer or rebate.
Richard Beckwith, country manager of Jurox (UK) Ltd, said: "Jurox prides itself on providing customers with a range of high quality medicines and we believe the launch of Buprelieve will also satisfy vets’ increasing requests for competitively priced products. We understand that providing high quality pain relief is critical and Buprelieve helps vets deliver the care they demand for their patients."
For more information, contact your local Jurox technical advisor, telephone the customer services team on 0800 500 3171 or e-mail: info@jurox.co.uk.
Using 14 years’ of race day veterinary reports, the study found that soft tissue injuries, respiratory conditions and gait abnormalities were the most commonly reported issues. Soft tissue injuries include wounds and lacerations. Those classified as 'gait observations' primarily relate to horses reported as lame, moving poorly or being stiff, but without a specific cause being identified. The majority of horses with respiratory conditions had epistaxis.
Researchers say the findings will help prioritize efforts and direct research to identify risk factors for the most common and/or severe conditions, with the aim of developing strategies to further reduce injuries and fatalities in British flat racing, building on its already strong record on equine welfare.
Sarah Rosanowski, PhD PGDipVCS BSc, at the Royal Veterinary College said: "It was not surprising to find that most veterinary incidents reported on race-day are relatively minor and not career-ending. This is of course a good thing.
"Although the good news is that the majority of injuries are not life-threatening, the fatality rates in British flat racing have remained relatively stable rather than declining over the past decade.
"The ongoing surveillance by the British Horseracing Authority is important as it provides a way to track the occurrence of veterinary events over time. Now that we have a baseline against which to monitor the effects of future interventions, there will be opportunities to further improve horse welfare and racing safety."
Reference
Bob was a member of RCVS Council from 1992 until 2004 and was President in 1999/2000. During his time on Council he also served as a member of all of the major committees of that time, with the exception of the Disciplinary Committee, and chaired several of the subject boards for the RCVS Diplomas.
Current RCVS President Chris Tufnell said: "Bob was 100% responsible for my involvement with the RCVS, putting me forward for a working party in my first year in practice. Throughout his career he nurtured young professionals who he genuinely saw as the future and he was particularly dedicated to furthering and improving the education and development of veterinary surgeons, as demonstrated by his involvement in the RCVS Diplomas, the College’s continuing professional development (CPD) board and the former RCVS Trust.
"His dedication to our profession was exceptional and his kind and erudite observations, both public and private, were always welcome. We will miss him and our thoughts are with his family at this difficult time."
Photo courtesy Dulwich College.
Essential 6 spot-on is designed to moisturise the skin and strengthen its barrier function to help manage kerato-seborrhoeic disorders (dandruff, bad odours, dry or greasy coat, excessive hair loss) and atopic dermatitis in ferrets, rabbits, rats, hamsters, guinea pigs and gerbils.
Essential Mousse is a rinse-free and soap-free repairing cleanser, used to cleanse and deodorize the animal as often as necessary. In particular, the company highlights its application in clinic, for cleaning up after anal gland expression, incontinence or vomiting, for use in animals that cannot be bathed, and as a customer courtesy before discharge.
The complete Dermoscent range, including the new small mammal products, is available in the UK through Vet Direct.
Henry Schein stocks the 4 variants for cats, dogs and small mammals of Essential 6 spot-on.
More information can be found at the Dermoscent website www.dermoscent.com, where visitors can access clinical studies and watch Wayne Rosenkrantz’s webinar: "Current Treatment Options for Canine Atopic dermatitis".
Finn, a seven-year-old German Shepherd dog, sustained stab wounds to the head and chest as he and his handler, PC David Wardell, pursued a suspect in Stevenage. PC Wardell sustained stab wounds to his hand.
Finn was rushed to Roebuck vets in Stevenage where his wounds were dressed and he was stabilised before being transferred to Davies Veterinary Specialists near Hitchin for emergency surgery.
DVS soft tissue surgeon Rob Adams (pictured above) operated on Finn. He said: "For legal reasons we cannot disclose the full extent of Finn’s injuries. We are however able to confirm multiple knife injuries were sustained to his head and chest involving several of his vital organs. Major surgical intervention was required including open chest surgery to save Finn’s life. Several drains were placed after surgery to manage the degree of trauma and contamination risk from the knife. The surgery went very well and Finn was transferred to intensive care for recovery.
"It is a testament to Finn’s incredible bravery, tenacity and loyalty to his handler, to know he continued to stand firm in the line of duty with no regard to the extent and severity of the injuries he suffered."
DVS says that Finn has exceeded all expectations and recovered very quickly. He has been discharged back into PC Wardell’s care and will hopefully be back up and running again just before Christmas.
PC Wardell said: "I’ve had Finn since he was about nine months old and we’ve been out on the street for just over six years together. It’s just great to have him home. I knew he was in safe hands with Rob Adams but because of the extent of his injuries I was so worried I was going to lose him. Finn’s not only my loyal partner at work but he’s also a part of our family. He has a home for life with me - I can’t imagine life without him."
Meanwhile, a campaign is underway to give police dogs and horses the same status as officers if they are injured in the line of work, so that people who attack police animals face charges similar to those for attacking a person.
You can sign the 'Finn's Law Petition' here: https://petition.parliament.uk/petitions/168678
The campaign also has a twitter feed here: https://twitter.com/FinnsLaw
For every 'Proud to support Dogs for Good' profile picture changed and tagged with @PetMagicMoments and #dogsaregood, Elanco will donate £1 to the charity that trains dogs to give life-changing assistance to people with disabilities.
The company is hoping to raise up to £5,000 for its long-term charity partner through the Pet Magic Moments - https://www.facebook.com/PetMagicMoments/ - Facebook picture initiative, with an overall aim of raising in excess of £15,000 in total for Dogs for Good to support the training of three assistance dogs.
Elanco says it will raise additional money through fundraising activities and employees will also be encouraged to carry out voluntary work to support Dogs for Good in the three days a year they are given to volunteer for worthwhile charities.
Matthew Rowe, marketing manager at Elanco Animal Health, said: "Our Dogs for Good Facebook picture initiative will help highlight the profile of this wonderful and inspiring charity, while raising funds to support the training of an assistance dog."
Dogs for Good (the new name for Dogs for the Disabled) is an innovative charity, exploring ways dogs can help people overcome specific challenges and enrich and improve lives and communities.
Its assistance dogs support adults and children with a range of disabilities and also children with autism. It trains activity and therapy dogs to work with specialist handlers in communities and schools and its Family Dog team also gives specialist advice and support to help people get the most out of their relationship with their pet dog.
For further information about the charity, visit www.dogsforgood.org or call on 01295 252600.
The charity says it joins mounting evidence that brachycephalic cats, including most modern Persians or Exotic Shorthairs, are suffering from a number of health problems, including breathing problems, eye inflammation, skin infections and difficulty eating.
In the study, published open access in the journal PLOS ONE, cat owners were asked to complete a detailed health questionnaire and submit photographs of their cats so that researchers could measure the muzzle ratio and nose position ratio. 1000 valid questionnaires and 373 valid photographs were received.
The research confirmed that flatter-faced cats (of breeds such as the Persian or Exotic Shorthair), were more likely to have breathing problems and that the breathing difficulties were also associated with increased tear staining and a more sedentary lifestyle.
A previous paper, published in the Journal of Feline Medicine and Surgery (JFMS)2 showed how the skulls of brachycephalic cats are actually deformed, especially the nose and jaw.
The charity says that unfortunately, breeds of cat and dog with flat faces are becoming more and more popular, and extremes (of an already abnormal anatomy) can become instant internet celebrities. These breeds and individuals often have large or prominent eyes which are considered by some to be 'cute' because they are baby-like, and the flattened face often has an up-turned or down-turned mouth, which gives it a human or cartoon characteristic of smiling or scowling, such as Grumpy Cat.
Claire Bessant, Chief Executive of International Cat Care said: "It is very depressing to see the life which has been deliberately dealt to some breeds of cats because of a human desire to develop a certain look. I urge cat lovers to speak out and help others to understand that this is not something we should be doing to cats, and not something we should be tolerating.
"One of the best and most beautifully naturally designed animals – the cat – would not normally have any of these problems; we have created them through selective breeding.
"We should not be encouraging people to breed these cats by calling them 'cute', by being amused at their facial characteristics, or by the fact that they snore – rather we need to understand that this is human intervention that is wholly detrimental to the welfare of the cats and is simply cruel.
"International Cat Care takes an ethical view of all cat breeds and our website (http://icatcare.org/advice/cat-breeds) outlines the problems that exist for some breeds, including very flat-faced cats in the Persians and Exotic breeds. Our stance is that we should never deliberately breed cats for any feature or characteristic that impairs their welfare."
References
Enrolment is now open for the programme, which matches participants with an experienced supervisor and provides BSAVA support and guidance.
The Association says the qualification is intended to give veterinary surgeons the opportunity to investigate in more depth any aspect of clinical research relating to their work – in particular vets working in practice, including those who may be unsure how to take the first step.
It could be a special interest, such as evaluating risk factors for a particular disease or common case they see in practice, with experienced peers available in diverse areas – from exotics to ophthalmology and nutrition to internal medicine.
The Masters is a significant addition to the most successful CPD programme in the 60-year history of the BSAVA, spearheaded by Academic Director Frances Barr (pictured above right).
Frances said: "This qualification offers exciting possibilities for vets to unlock their inner researcher, finding answers to clinical questions faced in practice and guided every step of the way by highly experienced supervisors and the BSAVA team.
"It furthers the BSAVA’s mission to help vets realise their ambitions and develop through lifelong learning at every stage of their careers, which we hope will have a very positive impact on the profession."
The Masters programme, validated by Nottingham Trent University, is aimed at people who already have any accredited postgraduate certificate (60 credits at Level 7) relevant to some aspect of veterinary medicine or surgery.
It is based on a further 1,200 study hours and could be flexibly achieved in two years of part-time study or up to five years, depending on the project type and an individual’s availability. It starts with online study into the principles of clinical research, which students will then apply to their own research project.
The programme starts in January 2017 and applications are now open.
Students can enroll online and find out more information at www.bsava.com or by emailing masters@bsava.com.
The Disciplinary Committee made its decision last Friday, following an adjournment of the case, which was initially heard in May of this year.
There were three heads of charge against Mr Hough:
The Committee found the majority of the first head of charge not proven, with the exception of the charges that Mr Hough failed to provide and ensure adequate overnight care for Mya and that it was inappropriate and unreasonable for him to plan for the wound management to be undertaken by Mya’s owners following the second procedure on 21 May 2014.
Regarding the second head of charge, the Committee found it proven that Mr Hough did fail to provide information about post-operative care and out-of-hours cover details to Mya’s owners. However it found Mr Hough’s failure to communicate with the owners regarding treatment options and to provide them with adequate information as to Mya’s post-operative condition not proven.
The third head of charge in its entirety was admitted and found proven.
The Committee also found that those charges that were found proven amounted to disgraceful conduct in a professional respect with the exception of Mr Hough’s failure to provide and/or ensure adequate overnight care and his failure to failure to provide out-of-hours details to Mya’s owners.
In deciding on an appropriate sanction, the Committee expressed significant concerns over Mr Hough’s treatment of Mya, in particular his "failure to devise and implement proper and sufficient procedures to ensure that this dog was not released to owners unless it was safe for her to be released and... that the owners were fully advised as to what was required of them."
The Committee felt that Mr Hough had given "insufficient attention" to Mya’s post-operative care but did accept that the conduct represented a single incident. During the course of the hearing the Committee also heard mitigating evidence given on behalf of Mr Hough, with a number of written testimonials as well as witness evidence in support of his clinical expertise and surgical skills.
The Committee accepted that Mr Hough had taken to heart the lessons to be learnt from the charges against him and had implemented a number of written protocols to prevent recurrence of the shortcomings in his treatment of Mya. Furthermore, the Committee also found that Mr Hough had demonstrated insight into the conduct found against him and that he had apologised for the disparaging remarks he made about other veterinary practitioners.
Alistair Barr, chairing the Disciplinary Committee and speaking on its behalf, said: "In short, the Committee is persuaded that Mr Hough has made a good start in putting in place systems to ensure that the interests and welfare of the animals treated at his practice surgeries are not discharged from care until they are fully ready to be discharged and that the owners of such animals will, in future, be fully informed of what might be asked and required of them when their animals are returned into their care after surgery."
He added: "There are no other areas of [Mr Hough’s] professional practices which appear to the Committee to call for improvements. Accordingly, the Committee is persuaded on this evidence that there is reason to believe that the lessons which Mr Hough needed to learn have been learnt and concludes, therefore, that the sanction of a formal and solemn reprimand adequately meets the needs of the public interest in, and requirements of, this particular case. Mya did make a full recovery from her extensive surgery but she and her owners deserved better post-surgery advice and support."
DVS highlights that the phenomenon of large group veterinary businesses is on the rise: big corporations such as Pets at Home Vet Group have recently bought stakes in several of the UK’s biggest referral practices and CVS Group, for example, now owns more than 360 of the UK’s veterinary surgeries, including referral practices.
By contrast, Davies Veterinary Specialists has now reduced the shareholdings of its founder (Jerry Davies), financial director (Mike Thomas) and managing director (Clive Elwood), in order to increase the holdings of Ian Battersby (internal medicine), Ronan Doyle (soft tissue surgery), David Gould (ophthalmology) and Nat Whitley (internal medicine) and create 8 new shareholders: Louise Clark (anaesthesia), Nuria Corzo-Menendez (diagnostic imaging), Mike Farrell (orthopaedic surgery), Laurent Garosi (neurology), Mark Goodfellow (oncology), Patricia Ibarrola (internal medicine), Pedro Oliveira (cardiology), Peter Smith (neurology).
The company says that its increasing number of shareholders will build a more effective business democracy, and in turn help uphold its core values of integrity, professionalism, compassion and respect.
Clive Elwood said: "Maintaining our independence is important to us as a business because it ensures we retain the culture and ethos that provides leading multi-specialist care to all of our patients and exceptional service to our customers and referring colleagues.
"I am delighted we have managed to achieve this transaction, which represents the next stage in the development of our amazing practice. Retaining ownership means we can demonstrate that there remain alternative business models and career paths outside corporate practice. It is a pleasure to welcome such a fantastic group of new shareholders who will, I am certain, contribute greatly to our future success."
DVS says it will continue to evolve the management and governance structure of the practice as it grows. In the future DVS shareholders will set overall strategy and direction for the business and ensure effective governance by the Board of Directors. As well as clinical skills, the development of management and leadership skills will be encouraged across the practice. A strong commitment to learning, research, innovation and teaching will support the delivery of exemplary patient care.
To find out more visit www.vetspecialists.co.uk
The RVC has published the results of a study which showed that dogs treated with pimobendan at the preclinical stage of mitral valve disease (MVD) remained asymptomatic for an average 15 months longer and lived for significantly longer than the placebo group.
The EPIC study (Evaluation of Pimobendan In Cardiomegaly), published open access in the Journal of Veterinary Internal Medicine1, is the largest prospective veterinary cardiology study carried out to date. The authors say that the quality of the data it produced rivals that of human clinical trials.
The study was double-blinded, placebo-controlled and randomised. It took seven years to complete and involved 360 dogs across 11 countries in four continents.
To qualify for enrolment in the study, dogs had to be 6 years of age or older, have a body weight ≥4.1 and ≤15 kg, have a characteristic systolic heart murmur of moderate to high intensity (≥ grade 3/6) with maximal intensity over the mitral area, have echocardiographic evidence of advanced MMVD defined as characteristic valvular lesions of the mitral valve apparatus, mitral regurgitation on the colour Doppler echocardiogram, and have echocardiographic evidence of left atrial and left ventricular dilatation, defined as a left atrial-to-aortic root ratio ≥ 1.6 and body weight normalized left ventricular internal diameter in diastole ≥ 1.7, in addition to radiographic evidence of cardiomegaly (vertebral heart sum > 10.5)
In fact, the study was terminated early following an interim analysis as the evidence was considered conclusive and it was deemed unethical to continue to withhold treatment from the placebo group.
Adrian Boswood, Professor of Veterinary Cardiology at the RVC (pictured above right), led the research. He said: "Thanks to the EPIC study results, vets no longer have to adopt a 'watch and wait' approach to suspected preclinical cases of MVD. When a typical mitral valve murmur is detected, vets should now investigate further to look for cardiac enlargement. If demonstrated, this suggests the patient will probably benefit from treatment with pimobendan before the onset of clinical signs.
"It's great that as a trusted treatment, pimobendan has a wealth of safety data behind it in addition to that gleaned from the EPIC study, which can help support vets when prescribing it in this new way."
Adrian added: "As far as evidence-based medicine goes, this is about as good as it gets. The size and design of the study places it in the top-tier. The study was designed and run by an independent team of investigators and sponsored by Boehringer Ingelheim. We, as lead investigators, had the right to publish the results regardless of the outcome. This makes EPIC very special indeed."
In light of the findings, Adrian says vets should now consider testing early for signs of preclinical MVD, and in dogs with cardiomegaly secondary to preclinical MVD, consider the use of pimobendan to delay the onset of congestive heart failure and extend the asymptomatic period.
To read more about the EPIC study and results, visit www.rvc.ac.uk
The guidelines are designed to support veterinary surgeons, veterinary nurses and wildlife rehabilitators, in order to promote and achieve the best possible care and welfare for indigenous British wild animals in accordance with UK law.
The Society says that guidelines are needed because:
Mark Stidworthy, BVZS President (pictured above right), said: "The rescue and rehabilitation of wildlife by veterinary surgeons and wildlife professionals is highly valued by the British public, making a positive contribution to local communities, the health and welfare of individual animals and to conservation. We hope these guidelines will inform best practice in this area and ensure its continued success."
Theresa Amory, Chair of the British Wildlife Rehabilitation Council (BWRC) said: "BWRC aims to support and promote the professional integrity of wildlife rehabilitators. While we recognise that meeting all of these guidelines may be difficult (particularly for smaller scale rehabilitators) we hope that they will enable rehabilitators to work alongside veterinary partners with increased awareness and confidence in their own working policies and procedures."
Michael Stanford, BVZS Senior Vice President, Veterinary Defence Society Claims Consultant said: "The BVZS Wildlife Guidelines should ensure all stakeholders involved with wildlife rehabilitation are acting in the best interests of animal welfare, with the added reassurance that they are acting in accordance with UK law."
Liz Mullineaux, veterinary surgeon and one of the authors of the guidelines said: "Working with British wildlife has always been challenging, for both vets and rehabilitators, in terms of what is ethical, legal and of an adequate clinical standard. These guidelines clarify many of those things, describing best practice and achievable standards for this area of work."
The guidelines can be downloaded from: http://www.bvzs.org/images/uploads/BVZS_Good_Practice_Guidelines_for_Wildlife_Centres_011016_.pdf
According to the Pet Food Manufacturers Association, there are an estimated 1M pet rabbits in the UK. They are commonly presented for treatment in practice and clients are beginning to expect complex workups and high levels of veterinary care.
Ivan, who qualified from the RVC in 1999, has been taking on first and second opinion rabbit cases for over 12 years and was instrumental in developing the v-gel anaesthetic device for rabbits and other species (www.docsinnovent.com). Jo has worked in first opinion practice since 2007 and was the Blue Cross Veterinary Nurse of the Year in 2014. Asides from her nursing experience, Jo has been teaching rabbit husbandry and nursing to owners and nurses directly and also via the Rabbit Welfare Association since 2012. Jo and Ivan have also taught rabbit anaesthesia at the Western Veterinary Conference in the USA for the last 3 years as well as lecturing for the Rabbit Welfare Association in the UK.
Ivan said: "We’re trying to get rabbit medicine to be seen as an important CPD subject for vets and nurses. We’re going to be offering day courses and conferences with an enjoyable and challenging mix of small group teaching, problem solving, practical teaching and conventional lectures - making sure that all our courses offer a really enjoyable day out as well as being first class CPD. Our first course is on the 13th October in Berkshire and we’ll be offering many more courses and conferences in the future!"
For more information about LagoLearn and its rabbit CPD, visit: http://www.lagolearn.com
In a letter to Danny, RCVS President Christopher Tufnell wrote:
"As the regulator of the veterinary profession, we place an emphasis on the importance of evidence-based veterinary medicine. We therefore recommend that there should be a cautious approach to homeopathy for animals and that normal evidential standards should be applied to complementary treatments."
Danny said: "A cautious approach? What, like this claim by the BAHVS that homeopathy cures cancer?. Or would you say that this claim on national TV represents a cautious approach?
"Talking about homeopathy and normal evidential standards in the same breath is oxymoronic. If you apply normal evidential standards to homeopathy, it is completely ineffective and should not therefore be used in animals."
Mr Tufnell wrote: "We believe it is also essential that such treatments, until they can be proved, are complementary rather than 'alternative' and that they are therefore used alongside conventional treatment."
Danny said: "This argument makes sense whilst evidence-gathering for new treatment modalities. Homeopathy, however, has been with us since 1796. In that time, there has been no good evidence that homeopathy is effective for any condition. Against that, we now have the benefit of an increasing body of meta analyses that show it isn’t. How much more evidence does the RCVS require?"
Mr Tufnell wrote: "Whatever views there may be within the veterinary profession, it is clear that there is a demand from some clients for complementary therapies for their animals."
Danny said: "That may be true, but client demand is not an argument for prescribing medicines shown not to work. Nor should ill-informed client demand trump animal welfare"
Mr Tufnell added: "It is better that they [clients] should seek advice from a veterinary surgeon - who is qualified to make a diagnosis, and can be held to account for the treatment given - rather than turning to a practitioner who does not have veterinary training."
Danny said: "It makes no difference to the animal's suffering whether effective treatment is withheld by a layperson or a qualified vet. At what point do we trust the clinical judgement of vets who subscribe to this magical thinking? In the case of hyperthyroidism in a cat, at what point do we trust them to start giving proper treatment? Maybe when the T4 levels reach a certain number? Or when renal failure kicks in? Or when the cat loses a certain percentage of its body weight?"
Finally, Mr Tufnell wrote: "homeopathy is currently accepted by society and recognised by UK medicines legislation and does not, in itself, cause harm to animals."
Danny said: "I'm not sure how it is possible to claim homeopathy is 'accepted by society'. What constitutes 'societal acceptance'? The NHS says that: 'The ideas that underpin homeopathy are not accepted by mainstream science, and are not consistent with long-accepted principles on the way that the physical world works'; the Australian Government says: 'Homeopathy should not be used to treat health conditions that are chronic, serious, or could become serious.' Clearly homeopathy is far from being accepted by society.
"Even if it was, the argument that we should prescribe medicines because they are 'societally accepted' is no different to the argument that we should do so because there is 'consumer demand.' Both are plainly wrong. Presumably the RCVS wouldn't approve of veterinary surgeons prescribing antibiotics just because there is 'consumer demand', or because they are 'societally accepted'.
As to the veterinary medicines regulations, homeopathic remedies were ‘grandfathered’ and have not had to prove efficacy to become authorised. So their recognition by UK medicines legislation is meaningless.
"Lastly, homeopathy does, in itself, cause harm to animals when given ahead of, or in place of proven treatments."
At the same time as Danny was running his petition for banning homeopathy, the Campaign For Rational Veterinary Medicine has been running a petition which instead asks that the RCVS takes steps to allow animal owners to make a more informed decision, thereby limiting the harm that homeopathy causes animals.
This petition, which is for the veterinary profession only, has so far gathered over 400 signatures, and the campaign organisers are now inviting anyone who signed the petition to ban homeopathy to consider signing this one as a pragmatic alternative.
During the four-day hearing, the Committee heard evidence in respect of three separate heads of charge brought against Mr Shah following a castration operation conducted on Shadow, a six-year old Newfoundland dog, which took place on 20 June 2014.
The three charges were as follows:
There was no complaint made as to the undertaking of the operation itself, and the Committee followed the advice from the Legal Assessor that each charge should be considered separately. When making its decision, the Committee did not take into account the fact that Shadow had died as it is impossible to say whether he would have survived had Mr Shah acted differently.
The Committee found each of the allegations against Mr Shah proved. In respect of the first charge the Committee heard from two expert witnesses, Professor Williams and Mr Plumley, who agreed that the decision to discharge Shadow at about 6pm on 20 June 2014, given his condition, was inappropriate.
The Committee considers that discharging Shadow at that time into the care of the owner given his state on discharge, was grossly negligent and a serious error of judgement. It therefore found Mr Shah to be guilty of the first charge.
The Committee then considered that, after being alerted to Shadow’s continued lack of progress by the telephone call from Gemma Ballantyne between 30 and 45 minutes after discharge, Mr Shah exacerbated the situation by the inadequacy of his response in dealing with the concerns raised which, in the Committee’s view, represented a continuation of his previous poor judgement.
The Committee considered that Mr Shah was under a duty of care to advise Gemma Ballantyne to seek urgent veterinary attention for Shadow and by his own admission he failed to do so, and he was therefore found guilty of the second charge.
During that telephone call Mr Shah also gave no further details about the out-of-hours care available to Gemma Ballantyne other than to inform her that there would be an additional cost.
He did not seek confirmation that any such information been supplied by his colleague, Emma Martin (who at the relevant time was a student nurse), however, and at no time did he see Gemma Ballantyne in possession of the discharge sheet. The Committee therefore found Mr Shah guilty of this final head of charge.
The Committee did accept that there was no element of dishonesty, nor was there an aim of financial gain in the case. The Committee also considered that Mr Shah was acting in good faith at all times. It also accepted that Mr Shah was entitled to assume that normal practice had been followed and that a previously compiled discharge sheet, containing the number of the out-of-hours provider, had been supplied to Miss Ballantyne.
Ian Green, chairing the Committee and speaking on its behalf, said: "Balancing all of the factors as the Committee must, it is clear that on this occasion Mr Shah’s conduct fell far short of that which is expected and it therefore finds he conducted himself disgracefully in a professional respect."
Mr Green added: "In imposing the sanction of a reprimand, the Committee urges Mr Shah in the strongest possible terms to ensure that his future conduct by way of training and support systems within his practice are such as to avoid any possibility of a future incident such as this occurring in order to ensure animal welfare and public confidence in the veterinary profession. The Committee notes that in her evidence, Emma Martin said that the working practices at the surgery have been changed and the Committee expects that all animals kept in the care of Mr Shah are fully monitored, examined and assessed in relation to their condition before being discharged."
Specifically, the review is of The Non-Commercial Movement of Pet Animals Order 2011 as amended by the Non-Commercial Movement of Pet Animals (Amendment) Order 2014.
The consultation is seeking opinions on whether:
The consultation is not about potential changes to the legalisation following Brexit although evidence collected as part of this review may be relevant to future discussions.
The BSAVA says it is aware that the changes to the Pet Travel Scheme, introduced in January 2012 and December 2014, have significantly increased the number of animals, particularly puppies, entering the UK including those for sale which should not be coming in under the Pet Travel Scheme.
It says it also knows that a significant number of veterinary practices have been presented with animals that do not fully comply with the requirements of the Pet Travel Scheme and that contacting the appropriate department in the Local Authority is not always easy.
The Association is therefore encouraging members of the profession to feed into this consultation and encourage any clients who have experience of travelling to and from Europe with their pets to do so as well.
The BSAVA says it will be submitting a response itself, and if anyone would rather send their comments via the BSAVA, you should email Sally Everitt (Head of Scientific Policy) s.everitt@bsava.com by 20th October.
Amflee Combo, a POM, is being launched by a newcomer to the UK market, a Slovenian company called Krka (pronounced kirka). The company says it plans to introduce a vast range of small and production animal products onto the UK market in the next few years.
Killian Gaffney, Head of sales and marketing at Krka, says the company intends to support UK veterinary surgeons by offering high quality products and by building business relationships that will help protect veterinary incomes, at the same time as offering good value to their customers.
Killian said: "Amflee Combo has some unique features that we believe will set it apart from the competition. We know the combination of the two active ingredients in Amflee Combo is very effective for the treatment of fleas, ticks and biting lice and as part of a treatment strategy for flea allergy dermatitis in dogs and cats. S-methoprene is also effective against flea eggs and larvae in the environment.
"However, these ingredients can be susceptible to degradation when subjected to light and moisture, which is why each Amflee Combo pipette comes in its own special foil wrapper. The pipettes have also been designed for convenience of use, since we know that only 22% of owners apply spot-ons correctly1."
A range of product and client literature to support the use of Amflee Combo is available by calling 01753 722 150.
Amflee Combo is available in a variety of packs for cats and different sized dogs, containing either three or six pipettes. The recommended treatment is one pipette every four weeks.
Further information about Amflee Combo or Krka is available at www.krka.co.uk
1 El veterinario ante el cambio climatico Argos 107, 2010.
Almost all rabies cases are as a result of being bitten by an infected dog, with around half of all dog bites and rabies deaths occurring in children under 15 years of age. Rabies, which is preventable, is categorised as one of the 17 Neglected Tropical Diseases by the World Health Organization (WHO).
The End Rabies Now campaign aims to significantly raise the profile of rabies as a global neglected tropical disease with policy makers and journalists, explaining what is being done to control and eliminate the disease. The campaign is led by Global Alliance for Rabies Control (GARC), and has three key messages:
Ahead of the tenth World Rabies Day, BVA has also recognised vet Professor Sarah Cleaveland OBE for her work in rabies control by awarding her the Chiron Award, one of the Association’s most prestigious awards for outstanding contributions to veterinary science.
Sarah said: "Awards like this are recognition of the contributions not only of one person, but the work of many. We are deeply committed to continuing our efforts towards the global elimination of canine rabies and tackling other zoonotic diseases that affect the health and livelihoods of many of the poorest people in the world."
The End Rabies Now campaign is based around the strong scientific evidence that vaccinating dogs is fundamental to disrupting the cycle of rabies transmission to humans. The target of 2030 was chosen because one of the UN’s sustainable development goals, launched in September 2015, includes the ambition to end by 2030 neglected tropical diseases such as rabies.
With 120 countries still affected by canine rabies, the End Rabies Now campaign advocates that collaborative cross-sector efforts are needed to end zoonotic diseases such as rabies: rabies elimination plans must include human and animal government agencies, veterinary and human health professionals, educators, scientists and community groups.
BVA President Gudrun Ravetz said: "The work being done worldwide by vets, human health professionals and others to combat this horrific disease that senselessly kills thousands each year is of the utmost importance and BVA is proud to support the End Rabies Now campaign and help get those key messages out to policy makers and governments worldwide – every rabies death is entirely preventable and we can end rabies by 2030 through vaccinating dogs."